Hyderabad: Minister Sirdhar Babu inaugurates bioMérieux’s TB diagnostic kits facility
By Newsmeter Network
Hyderabad: IT Minister D Sirdhar Babu inaugurated bioMérieux’s TB diagnostic kits manufacturing facility in Hyderabad.
Located in Hyderabad’s Genome Valley, the facility represents a major step forward in India's mission to eliminate TB. On this occasion, the minister also launched diagnostic kits for drug-resistant tuberculosis.
Minister Sridhar Babu emphasized that drug-resistant TB remains a formidable public health challenge because it fails to respond to standard medication.
"Early detection and timely intervention are critical to saving lives and preventing the spread of this disease," the Minister stated, praising bioMérieux for its strategic investment in the state.
A Landmark Partnership
The launch was attended by high-level French officials, including Marc Lamy, Consul General of France in Bengaluru, and Alexandre Mérieux, Executive Chairman of bioMérieux. The project highlights the deepening economic ties between Telangana and France:
Investment: bioMérieux has invested approximately ₹50 crore in the initial phase of the Genome Valley site.
Employment: The facility has already created jobs for 100 people.
Future Growth: Plans are underway to establish a dedicated Research and Development (R&D) laboratory at the site.
During the event, the Indo-French Chamber of Commerce and Industry (IFCCI) presented a report to Minister Sridhar Babu detailing the burgeoning bilateral trade relations and the pivotal role French companies play in Telangana's economic landscape.
Understanding TB Diagnostic Kits
Tuberculosis is caused by the bacterium mycobacterium tuberculosis. While standard TB is treatable with a six-month course of first-line antibiotics, Drug-Resistant TB (DR-TB) occurs when the bacteria develop the ability to withstand these drugs, usually due to inconsistent treatment or person-to-person transmission of resistant strains.
Evolution of Diagnostic Technology
Traditionally, TB was diagnosed using Sputum Smear Microscopy (looking at samples under a microscope) or Culture tests (growing the bacteria in a lab). However, these methods have significant drawbacks:
Microscopy often misses cases with low bacterial loads.
Cultures can take up to 8 weeks to provide results, which is too slow for urgent intervention.
The Role of Advanced Kits
Modern kits, like those manufactured by bioMérieux in Hyderabad, typically utilize Molecular Diagnostics (such as NAAT - Nucleic Acid Amplification Test).
Speed: These kits can detect TB and identify resistance to specific drugs (like Rifampicin or Isoniazid) in a matter of hours rather than weeks.
Precision: They look for specific genetic mutations in the bacteria that signal drug resistance.
Point-of-Care: Advanced kits are increasingly portable, allowing for high-accuracy testing in rural or under-resourced clinics, not just major hospitals.
By producing these kits locally in Genome Valley, Telangana is reducing the cost and increasing the availability of the tools necessary to meet India’s goal of ending TB by 2025.
